FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35546111000001107: Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107165201000001119 Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107165301000001111 Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Irinotecan 500mg/25ml solution for infusion vials true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has active ingredient Irinotecan true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) 1 vial Has AMP True Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start